CN1206963C - Injection for eliminating wrinkles and scar and its prepn - Google Patents

Injection for eliminating wrinkles and scar and its prepn Download PDF

Info

Publication number
CN1206963C
CN1206963C CNB03155833XA CN03155833A CN1206963C CN 1206963 C CN1206963 C CN 1206963C CN B03155833X A CNB03155833X A CN B03155833XA CN 03155833 A CN03155833 A CN 03155833A CN 1206963 C CN1206963 C CN 1206963C
Authority
CN
China
Prior art keywords
injection
scar
million
preparation
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB03155833XA
Other languages
Chinese (zh)
Other versions
CN1486702A (en
Inventor
韩斌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lv Weiguang
Original Assignee
Beijing Yiling Bioengineering Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Yiling Bioengineering Co Ltd filed Critical Beijing Yiling Bioengineering Co Ltd
Priority to CNB03155833XA priority Critical patent/CN1206963C/en
Publication of CN1486702A publication Critical patent/CN1486702A/en
Application granted granted Critical
Publication of CN1206963C publication Critical patent/CN1206963C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to an injection for eliminating wrinkles and scars and a preparation method thereof, which belongs to the field of tissue engineering. The injection is composed of ten million to fourteen million corium mechanocytes and 2 to 4 ml of glucose injection with the concentration of 5%. The preparation method comprises the following steps: corium mechanocytes which come from patients are in vitro expanded and cultured, and made into suspension according to that 2 to 4 ml of glucose injection with the concentration of 5% is added to every ten million to fourteen million corium mechanocytes. The present invention has the advantages that used biological materials are taken from patients and has the advantages of no rejection reaction or side effect, conspicuous beauty treatment curative effect, natural expression after being used by people to be treated. The effect is lasting and can be maintained for several years.

Description

Injection of a kind of Wrinkle-and scar-removing and preparation method thereof
Technical field
The present invention relates to injection of a kind of Wrinkle-and scar-removing and preparation method thereof, belong to field of tissue engineering technology.
Background technology
People adopt the collagen protein of injection cattle to treat wrinkle and cicatrix before 20 years, but it anaphylaxis can occur, can be organized simultaneously faster to absorb the time that can only keep some months.In order to overcome this anaphylactoid shortcoming, some hospital adopts and becomes collagen protein to inject from the body leather, and the result is that preparation process needs a large amount of skin, and still can be organized very fast absorption after the injection.Many in recent years people adopt creotoxin to inject and treat wrinkle and cicatrix, and its result also can only keep the relatively shorter time, and the expression utmost point of treatment back therapist is unnatural.
Summary of the invention
In order to overcome the weak point of these products, the purpose of this invention is to provide a kind of efficient, permanent, injection of the Wrinkle-and scar-removing of back nature more.
The autologous skin that this injection has adopted the people is isolated dermal fibroblast through digestion, carries out amplification in vitro, is then injected into the wrinkle or the cicatrix position of therapist, and these cells produce collagen tissue in its injection site, smoothes away wrinkles and fills and leads up cicatrix.
Another object of the present invention provides the preparation method of this injection.
For achieving the above object, the present invention is by the following technical solutions:
A kind of injection of Wrinkle-and scar-removing is made up of the glucose injection of 1,000 ten thousand-4,000 ten thousand dermal fibroblasts and 2-4ml concentration 5%.
Described dermal fibroblast is to obtain through amplification in vitro, cultivation deriving from the dermal fibroblast of patient from body.
A kind of preparation method of injection of Wrinkle-and scar-removing, be to derive from the patient to cultivate at amplification in vitro from the dermal fibroblast of body, add the glucose injection of 2-4ml concentration 5% again according to per 1,000 ten thousand-4,000 ten thousand dermal fibroblasts, make suspension.
The present invention a kind ofly is expelled to the Wrinkle-and scar-removing product that wrinkle, cicatrix position are repaired with patient's autologous skin cell external once more through propagation, after cultivating, collagen protein makes rill and cicatrix is long puts down thereby this product produces at these positions, smoothing away wrinkles and cicatrix can improve simultaneously the environment of local skin again, playing the effect of young U.S. face.
Advantage of the present invention: the biomaterial that the present invention uses is taken from the patient from body, and no rejection has no side effect, therapist with after improve looks evident in efficacyly, look natural, and the effect effect is lasting, can keep the several years.
The invention will be further described for the following specific embodiment.
The specific embodiment
The preparation of the injection of embodiment 1, Wrinkle-and scar-removing
One. from the extraction of body healthy cell
With behind 70% the alcohol disinfecting ear or arm inboard, use then 10% lignocaine and 100,000/ epinephrine carry out local surfaces anesthesia.Take off with the epidermis and the dermal tissue of cutisector with 4 square millimeters, put into tissue and preserve in the liquid (DMEM and 10% hyclone, U.S. Hyclone company), wound site is made a pin sew up, adhesive bandage covers.
Two. the preparation of cell suspension
1. tissue digestion (Sanya CO2 incubator): the skin histology piece is positioned over to add 2ml concentration in the 35mm culture dish be pancreatin/EDTA liquid of 0.05%, 37 ℃, 10 minutes; The DMEM+10%FBS culture fluid stops.
2. cell separation: postdigestive piece of tissue is shredded and breaks up with suction pipe.
3. centrifugal: the cell harvesting after dispelling to centrifuge tube, Backman company temperature control centrifuge, 25 ℃, 1000 commentaries on classics/min, centrifugal 5 minutes, abandoning supernatant.
4. primitive cell culture: add the low serum true chrotoplast culture fluid (Sigma company, the U.S.) of 1ml and blow outstandingly in centrifuge tube, 1 * 35mm culture dish is gone in inoculation; Sanya CO 2Incubator, 37 ℃, 5% CO 2, cultivate.
5. passage cell is cultivated: changed liquid 1 time every 2-3 days, go down to posterity after 50-70% compiles cell when cell reaches.
6. preparation injection: the dermal fibroblast after subculture in vitro separately to the 4-6 week, adding 2-4ml concentration by per 1,000 ten thousand-4,000 ten thousand fibroblasts is 5% glucose injection, is mixed with suspension.
Three. product detects
1. virus detects: after around skin histology is cultivated, get the check that culture fluid that 1ml contains cell send Beijing infectious hospital to carry out HIV and hepatitis virus, determine that this is virus-free cell.
2. immunoreation test: around the 0.1ml cell suspending liquid is carried out skin test (with penicillin skin test method) to the operation receiveing person, to guarantee not having immunoreation.
3. finished product detection
1) outward appearance: this product is the pale suspension.
2) sterility test: undertaken by " Chinese biological goods rules " (2000 editions) general rule " biological product sterility test rules " A/B item, the result meets aseptic requirement.
The storage of product and transportation should be carried out in 2 ℃-10 ℃, shady and cool, dry, the environment that cleans, avoid sunlight direct projection, non-corrosiveness gas, no weight.
Embodiment 2, clinical report
One. case standard (case load 28 examples)
1. include standard in: the age (comprised 55 years old) below 55 years old; The wrinkle person be forehead, near the eyes, perioral aging lines; The cicatrix person is acne, wound cicatrix (magnitude range no requirement (NR)).
2. exclusion standard: the age is patient more than 55 years old; Autoimmune disease is arranged; The chronic skin patient is arranged; The infection patient is arranged.
Two. prepare injection: the method according to embodiment 1 is carried out.
Three. treatment
1. check before patient's art: hematuria is routine, electrocardiogram, hepatic and renal function, HIV, HbsAg just.
With the injection site with 70% alcohol disinfecting, the lignocaine of local injection 1%, perhaps epidermis is with 2.5% lignocaine and the anesthesia of 2.5% Astral512 ointment.
3. standby in the syringe with 1.5ml cell suspension suction 3ml.
4. get No. 4.5 long syringe needles of 2.2cm, adopt multiple spot inclined-plane (20 °-45 ° of the angles of syringe needle and skin) that cell suspension is injected into the upper strata and the middle level of skin corium, the 15-20 point is chosen in each injection site, injects cell suspension 0.05-0.1ml at every.Should it be turned white the tension of injection site epidermis during injection, should make the injection site leave the disperse space during injection.Wrinkle or cicatrix portion are all injected, injected the back and used ice bag external application 2 hours.
Injection site has sensations such as mild swelling, numbness in the postoperative 24 hours, does not generally have other part and general reaction.
The course of treatment: general wrinkle injection 2 times, big wrinkle or cicatrix injection three times, per injection is 2-4 week at interval.
Four, clinical follow, nurse:
1. after the operation, apply injection place 2 hours with ice bag.
2. observe the situation of part and whole body.
3. secondary oral vitamin C every day (each 200mg, every day is 400mg altogether), perhaps the part is put on the skin and is contained ascorbic facial cream, about 6 months.
4. postoperative was prevented tanning by the sun and the careful zest cosmetics of using in 3 days.
Five. efficacy analysis
Through to the analysis of cases of 28 examples, wherein the case of a shot has 20 examples, double injection 8 examples are arranged, 6 months observing times, the result has 24 examples (its satisfaction rate is 85.7%) for my approbation of patient, and its wrinkle, cicatrix obviously disappear, and the dermal matrix situation obviously improves.
The person observed 2 years so far wherein to have the individualized treatment, the complete obiteration of its wrinkle, cicatrix, skin smooth and high resilience.

Claims (2)

1, a kind of wrinkle removal is removed the injection of scar, it is characterized in that: this injection is made up of the glucose injection of 1,000 ten thousand-4,000 ten thousand dermal fibroblasts and 2-4ml concentration 5%, dermal fibroblast wherein be origin come from the patient from the dermal fibroblast of body through amplification in vitro, cultivate and obtain.
2, the described wrinkle removal of a kind of claim 1 is removed the preparation method of the injection of scar, it is characterized in that: this method be with derive from the patient from the dermal fibroblast of body in amplification in vitro and cultivation, add the glucose injection of 2-4ml concentration 5% again according to per 1,000 ten thousand-4,000 ten thousand dermal fibroblasts, make suspension.
CNB03155833XA 2003-08-25 2003-08-25 Injection for eliminating wrinkles and scar and its prepn Expired - Lifetime CN1206963C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB03155833XA CN1206963C (en) 2003-08-25 2003-08-25 Injection for eliminating wrinkles and scar and its prepn

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB03155833XA CN1206963C (en) 2003-08-25 2003-08-25 Injection for eliminating wrinkles and scar and its prepn

Publications (2)

Publication Number Publication Date
CN1486702A CN1486702A (en) 2004-04-07
CN1206963C true CN1206963C (en) 2005-06-22

Family

ID=34156850

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB03155833XA Expired - Lifetime CN1206963C (en) 2003-08-25 2003-08-25 Injection for eliminating wrinkles and scar and its prepn

Country Status (1)

Country Link
CN (1) CN1206963C (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100415875C (en) * 2005-11-03 2008-09-03 毛曦 Process for preparing self-fibroblast by skin prefibroblast
CN100421731C (en) * 2006-01-11 2008-10-01 黄靖西 Injection liquid of human autogenous collagen living cell and preparation method thereof
JP2012530492A (en) * 2009-06-17 2012-12-06 アデランス リサーチ インスティテュート,インコーポレイティド Methods and compositions for increasing the ability of dermal cells to promote hair growth
CN102205146A (en) * 2011-04-12 2011-10-05 王影 Stem cell repairing material as well as preparation method and application thereof
CN108066820A (en) * 2017-12-28 2018-05-25 江苏艾尔康生物医药科技有限公司 A kind of auto derma fibroblast parenteral solution

Also Published As

Publication number Publication date
CN1486702A (en) 2004-04-07

Similar Documents

Publication Publication Date Title
CN100349556C (en) Use of autologous dermal fibroblasts for repair of skin and soft tissue defects
CN107823632A (en) A kind of mesenchymal stem cells MSCs parenteral solution and preparation method
CN104055795B (en) A kind of injectable implant and preparation method thereof
KR20070122315A (en) Soft tissue filler composition comprising autologous dermal cell and hyaluronic acid
CN102284082B (en) Facial fibrous protein composite filled and positioned in subcutaneous soft tissues, and preparation method thereof
Singh et al. Skin substitutes: an Indian perspective
CN109893542A (en) Stem cell excretion body concentrate gel preparation for treating erectile dysfunction and preparation method thereof and medication
CN100581502C (en) Human soft tissue filler for injection, and its preparation method
CN114276567A (en) Bionic hydrogel scaffold for tissue engineering skin construction and preparation method thereof
CN102233144A (en) Method for implementing subcutaneous tissue regeneration by using tissue engineering technology
CN1206963C (en) Injection for eliminating wrinkles and scar and its prepn
CN101306208A (en) Human liquid state derma preparation for injection and its preparation method
CN105169494B (en) A kind of preparation method of organization engineering skin
CN101088569A (en) Human skin filler for injection and its prepn process
CN1232233C (en) Tissue engineering corium and its preparation method
CN1297324C (en) Tissue engineering autologous complex skin and its preparation method
CN101804071A (en) Injection for treating skin defect and preparation method thereof
CN109646459A (en) A kind of water optoinjection instrument injection umbilical cord mesenchymal stem cells preparation and its application
CN1768856A (en) Method for preparing injection for removing wrinkles and scars
CN1768857A (en) Wrinkle- and scar-removing injection
CN109072185A (en) Enhanced pluripotent cell and microvascular tissue and its application method
CN101548988A (en) Injection for treating skin defects and preparation method thereof
CN1737129B (en) Artificial skin transplant and its preparation method
CN105326862A (en) Stem cell preparation for treating burned skin and preparation method thereof
Woodroof et al. Path to ‘One and Done’

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: LV WEIGUANG

Free format text: FORMER OWNER: BEIJING YILING BIOENGINEERING CO., LTD.

Effective date: 20060407

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20060407

Address after: 100022, No. 1707, Jianguo Road, No. 98, Jianguo Road, Beijing, Chaoyang District, A

Patentee after: Lv Weiguang

Address before: 101500 Beijing City Industrial Development Zone in Miyun Dashenglu No. 60

Patentee before: Beijing Yiling Bioengineering Co.,Ltd.

CX01 Expiry of patent term

Granted publication date: 20050622

CX01 Expiry of patent term